Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Era Group Inc (ERA), Cresud S.A.C.I.F. y A. (ADR) (CRESY): RIMA Senvest’s Latest Bullish Moves and Top New Picks

Page 1 of 2

Richard Mashaal‘s RIMA Senvest Management recently disclosed increasing its passive positions in Era Group Inc (NYSE:ERA) and Cresud S.A.C.I.F. y A. (ADR) (NASDAQ:CRESY). According to two new filings with the Securities and Exchange Commission, the investor owns 1.05 million shares of Era Group, which represent 5.13% of the company’s outstanding stock, and 25.55 million shares of Cresud (represented by 2.55 million ADSs), equal to 5.18% of that company’s common stock. In its latest 13F filing, RIMA reported holding around 866,000 shares of Era Group and 2.20 million sponsored ADRs of Cresud.

Era Group

In Era Group Inc (NYSE:ERA), RIMA Senvest initiated a stake during the first quarter of 2013, the same period when the company went public. The investor then proceeded to raise its stake in the company from the initially-held 196,500 shares, while the stock grew by 18% since its IPO. The latest acquisition of shares comes in line with several insiders reporting exercising their options to buy stock and selling parts of their holdings. One of them is Christopher Scott Bradshaw, the CEO, CFO, President and Director of Era Group Inc (NYSE:ERA), who at the end of last week exercised his options to acquire 25,000 shares and sold 3,624 shares at $20.97, holding 73,556 shares after the sale. Another shareholder of Era Group Inc (NYSE:ERA) is Chuck Royce’s Royce & Associates, which during the fourth quarter inched down its stake in the helicopter operations company by 7% to 902,200 shares.

Cresud S.A.C.I.F. y A. (ADR) (NASDAQ:CRESY) is a $1.0 billion Argentinian producer of agricultural commodities. The stock gained over 61% in the last 52 weeks, but since the fund initiated a stake with 57,600 shares during the first quarter of 2010, the share price has inched up by just 6.0%. Nevertheless, the company’s stock significantly outperformed the farm products industry, which gained 23% over the last three years. Among the funds that we track, RIMA Senvest is the largest shareholder of Cresud S.A.C.I.F. y A. (ADR) (NASDAQ:CRESY), followed by Murray Stahl’s Horizon Asset Management, which owned 1.02 million shares, according to its latest 13F filing.

RIMA Senvest is a particularly interesting fund to track, even though its equity portfolio is relatively small and stands at around $1.40 billion as of the end of 2014. What’s interesting about the fund is that its managers Richard Mashaal and Brian Gonick have set a very ambitious hurdle rate for their investments. According to a report by Bloomberg, Messrs. Mashaal and Gonick consider that the stocks they buy should have the potential to double or triple in value between one and three years. According to the same source, RIMA Senvest has often succeeded in its goal, with seven of its 20 largest positions gaining over 100 percent in 2013 and the fund posting a return of 79.4% for that year. Moreover, in the 17 years since its inception through December 2013, the fund had average returns of over 20% per year, including surges of some 230% in 2009, 169% in 2003, and a drop of 54% in 2008.

It’s not surprising that RIMA manages to post such impressive returns, since the fund focuses on small-cap stocks. These companies are usually underpriced and have a considerable intrinsic value that can be discovered over the years and send the stock higher. RIMA’s strategy is also aligned with the one that we have developed at Insider Monkey, which is also focused on small-cap stocks. Our strategy returned 132% between August 2012 and March 2015, beating the market by more than 70 percentage points.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!